Avanos Medical (AVNS) Liabilities from Discontinued Operations (2016 - 2024)

Avanos Medical has reported Liabilities from Discontinued Operations for 6 years, with the latest figure at 52900000.0 in Q3 2024.

• Quarterly Liabilities from Discontinued Operations rose 2016.0% year-over-year to 52900000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was 52900000.0 (up 2016.0% YoY) and the FY2023 annual result came in at 63700000.0, up 797.18% from the prior year.
• Liabilities from Discontinued Operations held at 52900000.0 in Q3 2024 per AVNS's latest filing, from 52700000.0 in the prior quarter.
• Over five years, Liabilities from Discontinued Operations peaked at 63700000.0 in Q4 2023 and troughed at 2500000.0 in Q3 2023.
• A 3-year average of 38516666.67 and a median of 52450000.0 in 2024 frame the typical range for Liabilities from Discontinued Operations.
• The sharpest annual moves came in 2023 and 2024: Liabilities from Discontinued Operations surged 797.18% in 2023, then jumped 2016.0% in 2024.
• Over 3 years, Liabilities from Discontinued Operations stood at 7100000.0 in 2022, then soared by 797.18% to 63700000.0 in 2023, then decreased by 16.95% to 52900000.0 in 2024.
• According to Business Quant data, Liabilities from Discontinued Operations over the past three periods registered 52900000.0, 52700000.0, and 52200000.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.